Ladies and gentlemen, thank you for standing by, and welcome to Brandywine Realty Trust's Second Quarter 2025 Earnings Call. Please be advised that today's conference is being recorded. I would now like to turn the conference over to Jerry Sweeney, President and CEO. Sir, please go ahead.

Michelle, thank you very much. Good morning, everyone. Thank you for joining our second quarter '25 earnings call. As usual, on today's call with me are George Johnstone, our Executive Vice President of Operations; Dan Palazzo, our Senior Vice President and Chief Accounting Officer; and Tom Wirth, our Executive Vice President and Chief Financial Officer. Prior to beginning, certain information discussed on this call may constitute forward-looking statements within the meaning of federal securities law. Although we believe the estimates reflected in these statements are based on reasonable assumptions, we cannot give assurance that the anticipated results will be achieved. For further information on factors that could impact our anticipated results, please reference our press release as well as our most recent annual and quarterly reports that we file with the SEC. Well, first and foremost, we hope that you and yours are doing well and enjoying the summer. And during our prepared comments today, we'll briefly review our second quarter results and provide updates on our 2025 business plan. After that, Dan, George, Tom and I are available to answer any questions. We posted solid operating metrics again this quarter, reinforcing the continued flight to quality, our portfolio's strong market positioning and our asset quality. As we will review, we are increasing our business plan ranges on retention, same-store growth from both a cash and GAAP standpoint, our capital ratio, and GAAP and combined mark-to-market. At the midpoint, we have now executed over 98% of our 2025 spec revenue target. Our quarterly retention rate was 82%. Leasing activity for the quarter approximated 460,000 square feet, including 233,000 square feet in our wholly-owned portfolio and 226,000 square feet in our joint venture portfolio. Quarter-over-quarter, leasing activity increased 35%, highlighted by our signing a 100,000 square foot lease with an industry-leading tech company at our One Uptown joint venture development. Forward leasing commencing after quarter-end remains strong at 280,000 square feet. Second quarter net absorption totaled 13,000 square feet. We do expect positive net absorption in the third quarter as well. As anticipated in our business plan, we ended the quarter at 88.6% occupied and 91.1% leased. The sequential increase in both our occupancy and lease percentage are primarily due to, as we outlined last quarter, reclassifying 300 Delaware into a redevelopment opportunity, the sale of Quarry Lake in Austin, and an asset now held for sale in our Austin portfolio. While we are 91% leased, we expect negative absorption in Q4 from a tenant move-out in Austin and several small leasing slides to Q1 '26. So we're holding our year-end leasing range at 89% to 90%. In Philadelphia, we're 93.5% occupied and 96.5% leased. During the second quarter, we captured 54% of all office deals done in the Central Business District. In the Pennsylvania suburbs, we're 88% occupied and 90% leased. In Austin, that is now 78% leased and occupied, up due to the sale of those 2 properties. Looking ahead, we have only 5.2% annual rollover through year-end '26, one of the lowest in the office sector, and only 7.5% through 2027. For the quarter, our mark-to-market was 2.1% on a GAAP basis and negative on a cash basis. We are increasing our range on both of these metrics, 50 and 75 basis points, respectively, based on leases we have already executed in both Philadelphia and the Pennsylvania suburbs. Our capital ratio was 4.1%, well below our '25 business plan range, primarily due to continued capital control, construction efficiencies and a number of as-is transactions. As such, we're improving our capital ratio by 0.5 percentage points at the midpoint to now 9% to 10%, which is the lowest capital ratio range we've had in the past 5 years. Tour activity continues to accelerate. In the second quarter, physical tours were 29% higher than in the first quarter, and the square footage toured increased by 66%. During this quarter, 43% of new leases were a result of a flight to quality on a wholly-owned basis. We do not have any tenant lease expirations exceeding 1% of revenue through 2026. Our operating portfolio leasing pipeline remains strong at 1.5 million square feet, which includes approximately 75,000 square feet in advanced negotiations. We expect ongoing strong performance in our operating portfolio, backed by limited rollover risk, effective capital management, improving market conditions, and a growing lease pipeline. On the balance sheet front, we issued $150 million in unsecured bonds in June, generating $159 million in gross proceeds with an effective yield to maturity just over 7%. We used part of this to pay down the line of credit created when we prepaid a $70 million term loan last quarter. Currently, we have no outstanding balance on our $600 million unsecured line of credit, along with $123 million in cash. We recently used some of these proceeds to reduce our secured debt by repaying our construction loan on 165 King of Prussia Road in Radnor and are in the process of prepaying a part of our secured CMBS loan. We also have no unsecured bond maturities until November 2027. Moving forward, to ensure sufficient liquidity, we plan to keep minimal balances on our line of credit. Our business plan is aimed at returning us to investment-grade metrics over the next couple of years. Therefore, we will focus on reducing overall leverage while retiring secured debt through unsecured banking or future bond offerings. Stepping back a bit and looking at the larger picture. Real estate markets and overall sentiment continue to improve. Our operating and leasing teams have established a solid operating franchise to capitalize on improving market dynamics. In particular, pipeline activity continues to grow quarter-over-quarter. Tour volume remains at very healthy levels. Rent levels and concession packages remain fully in line with our business plan. And in select submarkets and in select buildings, we are pushing both nominal and effective rents. The quality bifurcation continues in the office sector. As a way of example, Philadelphia's vacancy rate is about 18.6%, among 119 buildings. 50% of that vacancy is concentrated in just 14 buildings, while the top 10 vacancy buildings account for 40% of the city vacancy. High-quality buildings continue to outperform and push effective rent levels. Our competitive set, particularly in Philadelphia CBD and the suburbs, continues to narrow through both buildings being removed from office inventory for residential conversions and a select few assets continue to have financial issues, essentially removing them from the leasing market dynamic. In fact, our numbers show that potentially 10 buildings totaling several million square feet of office product is in the process of being removed from inventory for conversion to residential uses. As such, our Brandywine team and assets remain in an ever-improving competitive position. In looking at the city's life science sector, while early in the recovery phase, that should remain a forward growth driver backed by a strong regional health care ecosystem that includes 1,200 biotech and pharmaceutical firms along with 15 major health systems. Green shoots on the capital raising front are emerging as evidenced by the recent $200 million raise by a local life science firm. Austin, that's actually emerging from real estate market lows and remains a magnet for corporate expansion. Leasing momentum remains positive, particularly in the Class A property, with Austin recording over 121 tenants actively seeking almost 4 million square feet of space as of July. Positive momentum was driven by a revitalization of the tech sector. There's also a notable trend encouraging return to work on a full-time basis. So we are increasingly optimistic that Austin will see increased leasing activity as 2025 progresses. As noted, significant progress was made on liquidity and our operating property performance. Earnings, however, remained impacted by the expensing of our noncash preferred accruals, a negative carry on our JV development. By way of illustration, we are incurring $0.14 per share of negative carry in our development projects, including about $0.10 per share in noncash charges for our preferred structures on our JV developments. Looking at FFO, our FFO for the quarter was $0.15 a share and in line with consensus estimates. One point to note that we highlighted in our supplemental package in the press release is our 2025 business plan contemplated $0.03 a share in gains from land sales. We did anticipate these sales would occur in the second half of the year. Based upon the length of time required to perfect full site approvals and that being a condition to achieve optimal pricing, we do not believe all required approvals can be obtained by year-end. As a result, we removed these gains from our 2025 forecast. And as such, our revised FFO range is $0.60 to $0.66 per share, reflecting a midpoint still above consensus estimates. Optimizing value on our development projects remains the top priority in the company. And activity levels in all of our development projects significantly improved during the quarter, particularly at One Uptown and 3151. In fact, our overall development pipeline is up over 1 million square feet from last quarter. During the second quarter, we also had great success on residential developments at Avira, which has reached 99% leased, and Solaris now being 89% leased. At Schuylkill Yards, on our 3025 project, that commercial component is now 85% leased. To accelerate leasing on the 1 remaining floor, we are prebuilding space for delivery by year-end and have a very good pipeline of smaller tenants. We have executed 1 retail lease and are in advance negotiations on the final retail space. We continue to project the commercial component will stabilize in Q1 '26 shortly after our major tenant takes occupancy in January. Avira, the residential component, as I mentioned, is 99% leased and approaching full economic stabilization. 3151 Market, our life science project, was substantially delivered in the first quarter this year and will be in a capitalization phase through 2025. That pipeline has grown significantly since last quarter with advanced discussions underway with several prospects. The life science market remains in a recovery mode, impacted by a challenging fundraising climate and public policy uncertainty. Given the success of our 3025 office project, we're also conducting tours with office users. As I mentioned last call, despite the strong increase in office and life science traffic, visibility on lease executions and related build-out timelines still remains a bit unclear. So we did move the stabilization of that project back a quarter to Q4 '26. At Uptown ATX, traffic improved significantly over the quarter. And as highlighted earlier, we signed a 100,000 square foot lease and are now 40% leased. Our remaining pipeline remains strong with tenant sizes ranging between 6,000 and 100,000 square feet, including ongoing discussions and negotiations with several full-floor users. We are also proceeding with building out a spec space on 1 floor to accommodate the accelerated move-in dates for several smaller prospects. Those suites will be completed in early Q1 '26. Solaris, which opened 10 months ago, is currently 77% occupied and 89% leased. And we expect Solaris to fully stabilize in early Q4 of this year. As noted in the past, our development projects remain top of market and attractive to a broad range of our customer targets. We continue to remain confident in their success and we'll continue our aggressive marketing campaigns. Also, as these projects stabilize, they present an excellent opportunity for refinancing and recapitalization. We do anticipate making progress on this front with at least 1 and possibly 2 projects being recapitalized in the second half of this year. We expect these recapitalizations to retire the preferred investments, recover invested capital, improve our financial metrics and earnings, and reduce overall leverage. Our original 2025 business plan contemplated 1 development start during the year. So during the second quarter, we did commence construction on the last component of our overall Radnor mixed-use complex, a 121-room hotel situated adjacent to our 2.1 million square foot office life science portfolio in Penn's medical campus. The project cost is slightly less than $60 million, and we anticipate a 10% return on cost. The hotel will serve as an excellent amenity for our Brandywine tenant base in the adjoining universities. And based on surveys with our existing tenant base, we anticipate over 25% of the demand will come from the existing Radnor tenant base. In addition, there are 7 colleges within a 5-mile radius and an adjoining Penn medical complex. The project will be flagged by one of the world's leading brands and fully managed by the world's leading third-party hotel management company. Our plan is to finance these costs through the application of current and future sale proceeds and potentially a construction loan. The project will be completed in Q2 '26 and open for business shortly thereafter. Our 2025 business plan also anticipated $50 million of sales occurring in the second half of the year. We're pleased to report that we have sold or are firmly committed to sell almost $73 million of properties. The average cap rate on these sales was 6.9%, with a price per square foot of $212. We will continue to market several select assets during the balance of the year, but at this time are not factoring any additional sales into our '25 plan. We had an excellent quarter controlling capital spend as evidenced by a tightening of our capital ratio to 9% to 10% of lease revenues. As I alluded to earlier, our metrics have remained impacted by deferred tenant allowances and the noncash expensing of the preferred dividends. However, as NOI from development has come online and those projects are recapitalized, our plan contemplates growing both our FFO and CAD results to bring our dividend payout ratio back to historic levels. During the second quarter, by way of reference, we recognized approximately 26% of the deferred tenant improvement costs, totaling $5.5 million or $0.03 per share in our CAD ratio. In addition, the CAD ratio for the quarter included $0.02 or $3.8 million of accrued but unpaid preferred dividends. We do anticipate the large majority of those preferred returns will be paid upon the recapitalization of these joint ventures and not from cash flow. Each quarter, we do assess the ability to return to historic CAD coverage ratios over the next succeeding 4 to 6 quarters. As previously noted, we carefully monitor the timing of NOI coming from development projects, ongoing capital spend, intermediate-term coverage ratios and our plan to return to investment-grade metrics in determining our quarterly dividend policy. So with that overview, let me turn the floor over to Tom to review our financial results for the second quarter and outlook for the balance of the year.

Thank you, Jerry, and good morning. Our second quarter net loss was $89 million or $0.51 per share, which included impairments in our Austin portfolio totaling $63.4 million or $0.37 per share. Our second quarter FFO was $26.1 million or $0.15 per diluted share, meeting consensus estimates. In terms of observations for the quarter, FFO contribution from our unconsolidated joint ventures was a negative $5.8 million, which was $800,000 more than our reforecast of $5 million. This loss was partly due to higher concessions at our Solaris House during lease-up, and we expect those to improve over time. Interest expense was $0.5 million, lower than our reforecast, mainly due to capitalized interest. Other forecasted quarterly results were generally in line. Regarding our debt metrics, the second quarter debt service and interest coverage ratios were 2.0, a slight decrease of 0.1 from the first quarter. Our second quarter annualized combined and core net debt to EBITDA ratios were 8.3 and 7.9, respectively, both of which are within our business plan range. Looking at our core portfolio composition, we've made several changes. As highlighted previously, we are removing 300 Delaware from our core portfolio and placing it into redevelopment, which is anticipated to commence in 2026. We have sold Quarry Lake and we have 1 other Austin property held for sale. During the third quarter, we will add our life science redevelopment project located in Radnor, Pennsylvania, 250 King of Prussia Road, to the core portfolio as it will be stabilized. Liquidity and financing activity. As Jerry mentioned, we completed a follow-on bond offering in June, which generated gross proceeds of $159 million. The proceeds were used to repay an unsecured line of credit and pay off our construction loan at 155 King of Prussia Road, which is 100% occupied and now paying cash rent. We are working with our servicer to partially repay a portion of our secured term loan to increase our unencumbered asset pool. It's important to highlight that in April 2024, we executed an unsecured bond issuance at 8.875%, and this recent follow-on issuance had a yield to maturity of 7.04%, representing a 20% decrease in our unsecured borrowing costs. We continue to maintain a strong liquidity position, and we will use sales and refinance proceeds to reduce secured debt and to improve our credit profile and related credit outlook and rating. We have time to work on this improvement with no unsecured bonds maturing until November 2027. Our wholly-owned debt is 98.1% fixed, with a weighted average maturity of 3.3 years. As we highlighted, we are adjusting and narrowing our guidance for 2025. The midpoint reduction of $0.03 per share is due to removing the anticipated land sales from our guidance. And we also narrowed the guidance by $0.04 a share. As Jerry noted, we expect to recapitalize our residential and commercial developments as our leasing percentages approach 90%. We either achieved or are reaching those levels with several projects, and we will commence those recapitalization efforts over the balance of the year. We are anticipating some benefit in the 2025 results, with full benefit being realized in 2026. Looking at the third quarter guidance. Property-level operating income will total approximately $71.5 million and will approximate the second quarter results. FFO contribution from our joint ventures will total a negative $5 million, which is consistent with our second quarter results. Our G&A expense for the third quarter will total approximately $8.5 million, representing a sequential decrease totaling $800,000. Consistent with prior years, the sequential decrease is primarily due to the timing of our equity compensation expense recognition. The interest expense will be approximately $34.5 million and capitalized interest will be approximately $2.5 million. The sequential increase in interest is primarily due to the $150 million unsecured bond issuance, partially offset by actual and anticipated debt paydowns. Termination fees and other income will total about $1.5 million. And net management and development fees will be about $2 million. The sequential decrease is primarily due to lower forecasted construction development fees due to lower capital costs being incurred at our development properties. Our previous 2025 business plan included speculative sales totaling $50 million, which we anticipated would be towards the second half of the year. Although we have other assets on the market, we are adjusting our disposition guidance to $72.7 million, representing the sale in the second quarter and our anticipated sale in the third quarter. We anticipate no property acquisitions. We anticipate no ATM or buyback activity. And our share count will be roughly 179.5 million shares. Turning to our capital plan. Our capital plan for the balance of the year totals $215 million, and is fairly straightforward with some adjustments based on recent activity. Our 2025 CAD payout ratio for the second quarter was 176%. We recognize this is a very high, elevated level compared to our historical average and our long-term target. As Jerry outlined, our quarterly CAD ratio was negatively impacted by older tenant allowances and unpaid preferred dividends in our unconsolidated development joint ventures. Long term, as we complete these developments and experience higher operating income, we anticipate our CAD coverage ratio should decrease throughout 2026. Looking at the larger capital uses, we have development spend totaling $55 million, which includes 250 King of Prussia Road, a food hall at One Drexel Plaza, and our recently announced development in 165 King of Prussia Road. We have $52 million of common dividends, $15 million of revenue-maintaining capital and $20 million of revenue-creating capital, with $30 million allocated to equity contributions to fund recently signed tenant leases in our joint ventures. The funding sources are $62 million of cash flow after interest payments, asset sales, and construction loan proceeds, if we get a construction loan on 165 King of Prussia Road. Based on the capital plan, we anticipate using an incremental $81 million of cash during the balance of the year, with $42 million of cash, and no outstanding balance on our line of credit. We also project our net debt to EBITDA to range between 8.2 and 8.4, with the increase primarily due to losses from the joint ventures, developments. Our net debt to GAV will approximate 48%. We excluded the CMBS payoff from our sources and uses. So if we are successful in repaying a portion of the secured CMBS loan, we will have another use of cash and likely have a small line balance by the end of the year. By the end of 2025, our core net debt to EBITDA range will be 7.7 to 7.9 and should come close to equaling our consolidated net debt to EBITDA, which excludes our joint ventures. We anticipate our fixed charge coverage and interest ratios will remain steady at 2.0. And with incremental income on the development projects, we expect these leverage levels will begin to improve as we go into next year. I will now turn the call back over to Jerry.

Thank you, Tom. So as we look ahead, the operating platform, I think, really puts us in a great position to capitalize on improving real estate market conditions and perform at the high level we have been in the past couple of quarters. We're very encouraged by the significant increase this quarter in our pipeline for our development projects. And while we know that pipeline has not yet translated into definitive earnings growth for the company, we're very focused on that. So the groundwork has been laid, and we are focused on continuing that prospecting and lease execution momentum in our development portfolio. The operating platform remains very stable with limited near-term rollover. Our liquidity, as Tom outlined, remains in excellent shape. And we're well positioned to take advantage of continued market improvement. So with that, Michelle, we'd be happy to open the floor for questions. We do ask that, as we always do, in the interest of time, you limit yourself to 1 question and a follow-up.

And the first question will come from Seth Bergey with Citi.

As you think about the recapitalization of the development projects, can you just talk about capital provider appetite and how much you'd potentially look to encumber what that would look like?

Yes, we have many discussions in progress and are quite pleased with the level of interest from investors. This reflects the overall investment market for office space, which has seen a significant return of high-quality private investors eager to benefit from improving market conditions. Currently, all our development joint ventures are structured on a preferred basis, with Brandywine being the majority owner. Our goal with these recapitalizations is to maximize value at the time of transaction closure, whether that means selling some properties or entering into joint ventures that would return capital to us, reduce overall leverage, and lessen the earnings drag from a few properties. We have active discussions happening, as Tom mentioned, and we are waiting for some projects to reach quantitative stabilization before engaging in detailed talks with potential investors. Overall, we are on track to complete one or perhaps two of these projects this year, and we remain very optimistic about the broad activity we're seeing and the number of inquiries from private investors wanting to collaborate with us on future development projects.

And then as my follow-up, is the hotel development something you'd like to own longer-term, or would you kind of, upon completion, look to sell or monetize that in some way?

Yes. No, I think that's a great question. And look, on the hotel, look, from a cost of capital standpoint, I mean, starting the project was a bit of a challenging call for us. But from that perspective, I think the factors that went into it were, as we've talked on the call, our liquidity is in excellent shape with ample capacity. And I think certainly exceeding our sales target for the year and doing it earlier further improved liquidity and intermediate-term capacity. When we look over the next several quarters, to follow up on your initial question, yes, the recapitalization of our JV developments are going to result in lowering our overall leverage and improving our overall credit metrics. We believe those efforts will also improve overall liquidity by, as I mentioned, returning some capital to us. And that process is underway. And we remain focused on remaining on a track to return to investment-grade metrics. We know the operating platform will continue to perform well. Development leasing continues to make good progress with 4 of the 5 projects on that clear path to stabilization and recapitalization. And to go to your core question, I think as the hotel project progresses, we'll certainly look for additional equity partners or a JV or an early sale to further reduce the overall dollar exposure. But looking at those cost of capital considerations, we also wanted to balance that with what we viewed was an outstanding real estate opportunity.

Congrats, first of all, on the signing of 100,000 square feet at Uptown ATX. I was just wondering if you could talk maybe a little bit about the deal economics there, if there was maybe better or in line as how you expected at the end to kind of like come in getting signed? And if there's any interest for the tenant potentially to further grow their footprint there, or kind of how you like size it up? And if you could maybe touch on, in case you can disclose it, when do you expect that lease to commence and start actually seeing like rent for that tenant to be paid here?

Right. Well, I'll share with you what we can. It's a 10-year lease. We anticipated the tenant taking occupancy early '26. The economics were very much in line with our 10-year projections. Capital costs were a little bit above our initial budget, but the overall length of the lease and the economics of the lease compensates us for that. We certainly hope the tenant would continue to grow. They have a good footprint in Austin. They certainly indicated they continue to want to grow their presence in Austin. The lease has been structured to give them a right on some space in the building, but also then an ongoing right to match other deals that we bring to the table. So we've created some optionality for them to do some near-term growth, but then also further optionality for them to accelerate their growth curve by taking advantage of the right offer they have on spaces that we're ready to lease to third parties. So all in all, we think a very, very good outcome for our project Austin. We think having this named company as part of our Uptown development will certainly accelerate additional tenants wanting to move into our complex. So we're very happy with the result. And we've already seen, with that word leaking out into the marketplace, an uptick in activity through our Uptown pipeline. So a good result. It took us a long time to get there, but we're there and moving forward. And we'll be up and running in early '26.

Perfect. And maybe a quick follow-on just on the office components, the JV assets. I understand it's still further out in the future, of course. But like what lease percentage are you kind of targeting before even a recap of those office components would come into play as well? Understanding this is further out in the future.

Yes, that's a good question. We're currently focusing on the 3025 project, aiming to reach 85% leased and have a clear pathway to exceed 90% leased in the next few quarters, which is a key goal from a recapitalization perspective. Additionally, with Solaris House at 99% leased and expected to reach high 80s occupancy soon, we see that as a recapitalization opportunity. For One Uptown and 3151, we anticipate getting to the 60% to 70% leased range, with visibility on stabilizing those properties before we actively engage with direct private equity sources.

Jerry, you made some comments around the dividend, and I understand it's a Board decision, but you guys have also been pretty clear about just improving the balance sheet and the focus there. Just like do you have to pay a dividend right now? What kind of flexibility do you have? And how are you thinking about it?

Yes. Great question, Tony. Look, I think it continues to be a topic we review with the Board on an ongoing basis. And just by way of background, I think the factors that we really key in on are what the core portfolio performance looks like into '26, which we have some good visibility on; the timing of when the NOI from developments come online and the impact that has on '26; the burn-off rate for the tenant fit-out dollars for those leases that were signed as early as 2020. We do anticipate most of that burning off this year, if not all of it. And then most importantly, or perhaps most importantly, the execution timeline on the development project recaps that eliminate that preferred return charge to earnings. And as I mentioned a bit ago, I mean we do anticipate the second half of the year being really key in those recapitalization efforts as well as making a dividend decision. And then certainly, our view on how, with the capital market conditions, and how that impacts our projected time line to return to investment-grade metrics. So I think as we look at going into the second half of the year, we certainly are going to get a lot more clarity on how these recaps will take place and what the impact is on the balance sheet, our earnings and financial metrics, overall leverage levels. And I think that will be a defining moment for us to decide what we want to do with the dividend.

Okay. What is the flexibility regarding your current payouts or your tax situation?

Tony, our dividend will be dictated partially on some of the sales and whether we incur some losses. But we do have room to move the dividend down without having a trigger on our REIT requirements. So it could go pretty low without hitting that. But I do want to point out that depends on getting the sales done, because some of that is predicated on us getting some of these deals done. And as you know, we took an impairment, but we will also subsequently have a tax loss. So that gives us some flexibility that the dividend can be reduced if we decide to go that way.

Okay. And then just my other question relates to just general liquidity for office assets in the market. I mean you talked about a 6.9% cap on the $73 million of dispositions, seems pretty decent. And just can you talk to depth of market? What can be sold these days, what can't, where cap rates might be and so forth?

Yes, I think it's encouraging that nationally, office sales have surpassed last year's figures significantly. This trend has been largely driven by a resurgence of private investors interested in acquiring high-quality assets. Looking at 2023 and 2024, many of the office assets being traded were either distressed or of lower quality. However, we are beginning to see higher-quality assets entering the market, and the interest among investors is growing, not just from syndicators and family offices, but also from Tier 1 and Tier 2 institutions who are eager to capitalize on what they see as a recovery in the office market. Additionally, in many areas, we are anticipating a reduction in office inventory due to conversions to residential properties. While I can't predict exactly where cap rates will settle, I believe that higher-quality assets are likely to return to cap rates seen several years ago.

I wanted to focus a little bit on 3151. I know you kind of talked a little bit about kind of touring activity at that asset. But curious what the mix is between kind of life science touring versus kind of other potential tenants. And if you do end up doing a little bit more office in that building than initially anticipated, what the potential implications will be for the stabilized yields?

Yes, the pipeline actually has a couple of larger office requirements in it right now that have surfaced in the last quarter. They are kind of in the 6,000 to 100,000 square foot range. But the majority of the pipeline remains institutional, academic and life science. And a lot of the life science companies we're talking to are very interested in the building, but they need to raise some capital before either party is comfortable moving forward. So I think the recent announcement on a life science company locally being able to raise capital has been very, very positive. But I think when we take a look at the economics, the economics between the life science and the office are not that different because the capital requirements are lower. So we get a lower rent on the office, but a much lower capital cost number. I know we're still trying to get between 7- and 10-year deals. A couple of the transactions we're looking at are beyond that. But from an economic equivalency standpoint, they're pretty much in the same range.

Got you. That's helpful. Regarding the potential recap activity in the second half of '25, Tom, I think you mentioned that there might be some impact on '25, with the full positive impact occurring in '26. I'm just wondering if any of that is included in the '25 guidance.

There is some potential for improvement in our guidance if we complete certain tasks. We haven't specified the exact timing or details in our calculations. However, we believe we could achieve a few cents of improvement by completing the recaps sooner rather than later. This is also contingent on the timing of completing that transaction. If it takes longer, the impact could be less significant.

Got you. And if you just indulge me for one more, please. The move-out in fourth quarter of '25 that you guys mentioned, can you just talk a little bit about the overall size of that, again, just the implications for occupancy as you kind of begin 2026?

Sure, Tayo. It's George. It's a 70,000 square foot tenant who had an early termination right, which they have exercised. And they will vacate in October. Tenant was taking advantage of a sublease opportunity for a much smaller footprint than what they had with us. So we will see fourth quarter retention kind of below our annual range. We're still projecting to be between 88% and 89% occupied come year-end. And again, our forward leases that we've already executed kind of keep us in that range. And then some of those will also commence in '26.

And our next question will come from Upal Rana with KeyBanc Capital Markets.

On Uptown ATX, Jerry, you mentioned there continues to be a healthy pipeline there. Could you give us some additional color on that pipeline? And are you trading paper on any of them?

We are trading paper on a couple of them. And George, you want to walk through the pipeline?

Yes, the pipeline includes a variety of companies, primarily in financial and professional services, with a few tech firms involved. We are currently in advanced discussions with two or three of these tech companies, one of which is expected to be a full-floor user. Overall, our tour levels are encouraging, and the number of proposals issued has increased. We're optimistic about finalizing one of these deals soon.

That was helpful. Now that 300 Delaware and Quarry Lake are addressed, only a few properties remain affecting your vacancy portfolio. Can you update us on the other five properties and your strategy to reduce vacancy there?

We can work together on this. Right now, our main focus is on River Place, which is a two-pod complex with six buildings that has been underleased for a while due to several tenant move-outs and lease expirations. We are not currently leasing a couple of buildings there. We have submitted a rezoning permit application and anticipate receiving final zoning approval this quarter. We plan to move forward with several hundred apartment units, which has led us to shorten our hold period. We have a strong team in Austin that is well connected with the local community and politics, navigating these dynamics. Additionally, a new state bill has passed that speeds up the rezoning process from commercial to residential, and we're monitoring how that develops locally. If we achieve the zoning approval we anticipate, we will proceed with our full development plans and engage with the site approval process, confident in the support from local stakeholders. Four Points is currently underleased, and we continue to market it. That property is also on the market for sale, and we will see if any bidders emerge. At Cira Centre, we are involved in life science projects and are working on graduate labs with promising prospects. We believe this will take care of itself in the coming quarters. We are actively leasing River Place - Building 1 and are considering selling the office pod of River Place, so we'll monitor market response. Recently, we completed a major lobby renovation at 101 West Elm in Conshohocken, and we're making steady progress each quarter to lease that space, aiming to eliminate the vacancy of about 60,000 square feet. I hope this information was helpful.

Jerry, I understand you mentioned some strategic reasons for initiating hotel development. However, from a financial standpoint, part of why your shares are trading where they are can be attributed to the significant development you've undertaken in recent years during a challenging period, which has caused some ongoing issues. It's quite surprising that you would proceed with this new project considering your current share price and the development challenges you're already handling. Could you elaborate on the financial rationale behind this decision, especially given the scarcity of capital for Brandywine? With the sales coming in, why not allocate that capital toward share buybacks or reducing the company’s debt?

Look, a fair observation. I think on one of the previous questions, I kind of walked through the thought process from a cost of capital standpoint. And I do think that given the level of success we think we'll have with this development, that we will have some capital options available to us to reduce our financial exposure over the near term. So it was really kind of balancing the returns we thought we could get on this, what we view as a really strong window of opportunity to create a valuable piece of real estate, that really does play into the request from a lot of our tenants in that marketplace. So balancing from a tenant service platform. And certainly, we would expect to continue marketing properties for sale, as we just walked through, and continuing to lease up the development price. I think one of the big variables right now is the level of success that we think we will have with these recapitalizations. So I think with really 4 of the 5 projects having a visible path to stabilization and capital market conditions continue to improve, more investors coming back into the market both for office and residential, we think that we'll be in a very, very good position to address the financial considerations here. But thank you for your observation.

I am showing no further questions in the queue at this time. I would now like to turn the call back over to Jerry Sweeney for closing remarks.

Michelle, thank you, and thank you all for participating in our second quarter earnings call. We look forward to updating on our business plan activities and progress on the next quarterly call. Thank you all very much.

This concludes today's conference call. Thank you for participating, and you may now disconnect.